Pyxis Oncology raises $152m in Series B round for cancer therapies

pallavi123- March 30, 2021 0

Pyxis Oncology, a Boston-based biotech company, has raised $152 million in a Series B financing round co-led by Arix Bioscience and RTW Investments. The company ... Read More

Olema Oncology raises $54m for breast cancer drug candidate OP-1250

pharmanewsdaily- July 23, 2020 0

Olema Oncology, a California-based biopharma company focused on developing targeted therapies for women's cancers, has raised $54 million in a Series B financing round, which ... Read More

Protagonist Therapeutics secures $22m to advance IBD treatment

pharmanewsdaily- August 6, 2018 0

Protagonist Therapeutics, a clinical-stage biopharmaceutical company specializing in the discovery and development of novel peptide-based drugs, has successfully raised $22 million in new equity financing. ... Read More